One of the most exciting aspects of theranostics in early 2026 is "Personalized Dosimetry," which moves away from the "standard dose" approach used in traditional medicine. For a patient, this means that after their initial diagnostic scan, a computer model calculates the exact amount of radiation needed to destroy their specific tumors based on their body mass, kidney function, and how much...
Lutetium-177 PSMA radioligand therapy — the targeted radionuclide treatment delivering beta-emitting Lu-177 directly to prostate-specific membrane antigen-expressing prostate cancer cells — represents the most commercially significant radiopharmaceutical theranostics launch in the market's history, with the Radiopharmaceutical Theranostics Market reflecting Lu-177 PSMA as the...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china